Wall Street analyst estimates for None (HYFT): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
MindWalk Holdings Corp. functions as an innovative bio-native artificial intelligence firm. Its core mission involves leveraging the synergy of AI, comprehensive multi-omics data, and sophisticated laboratory investigations to accelerate the identification and advancement of biological therapeutics. Utilizing its proprietary LensAI platform and HYFT technology, the company forges partnerships with pharmaceutical and biotechnology enterprises.
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-12-21 | $-0.04 | ||
| 2026-09-14 | $-0.09 | $-0.05 | -64.7% |
| 2026-07-22 | $-0.06 | $-0.05 | -12.8% |
| 2026-03-12 | $-0.06 | $-0.04 | -50.0% |
| 2025-12-15 | $-0.05 | $-0.01 | -400.0% |
| 2025-09-15 | $-0.07 | $-0.04 | -75.0% |
| 2025-07-29 | $-0.04 | $-0.02 | -100.0% |
| 2025-03-28 | $-0.06 | $-0.06 | +0.0% |
Income Statement (10y)
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.6M | $5.4M | $10.9M | $14.7M | $17.9M | $19.4M | $20.7M | $24.5M | $24.5M | $15.3M |
| Cost of Revenue | $1.2M | $3.0M | $5.6M | $15.3M | $6.4M | $8.4M | $9.1M | $12.5M | $11.0M | $6.3M |
| Gross Profit | $1.4M | $2.5M | $5.3M | -$576292 | $11.5M | $11.0M | $11.6M | $12.1M | $13.5M | $9.0M |
| Research & Development | $660408 | $509248 | $485845 | $467292 | $2.0M | $7.7M | $14.1M | $4.0M | $4.9M | $4.9M |
| Selling, General & Admin | $2.0M | $5.8M | $8.1M | $3.2M | $13.3M | $18.1M | $19.0M | $19.1M | $19.0M | $18.9M |
| Operating Expenses | $2.8M | $7.4M | $11.5M | $3.7M | $15.7M | $27.7M | $37.2M | $25.8M | $25.7M | $23.7M |
| Operating Income | -$1.4M | -$4.9M | -$6.2M | -$4.3M | -$4.2M | -$16.7M | -$25.6M | -$13.8M | -$12.2M | -$14.7M |
| EBITDA | -$5.4M | -$4.3M | -$4.0M | -$1.2M | -$1.4M | -$12.0M | -$21.0M | -$22.9M | -$28.9M | -$13.1M |
| Interest Expense | $16775 | $84222 | $858323 | $736272 | $602372 | $85000 | $30000 | $19000 | $9914 | 0 |
| Pre-tax Income | -$5.5M | -$5.1M | -$7.6M | -$5.5M | -$6.0M | -$15.8M | -$27.8M | -$28.7M | -$34.3M | -$15.3M |
| Income Tax | -$82378 | $109715 | $4788 | -$362004 | $1.3M | $861000 | -$1.2M | -$2.6M | -$4.0M | -$443097 |
| Net Income | -$5.4M | -$5.2M | -$7.6M | -$5.2M | -$7.3M | -$16.7M | -$26.6M | -$26.1M | -$30.2M | -$13.7M |
| EPS | $-1.36 | $-0.57 | $-0.61 | $-0.36 | $-0.45 | $-0.87 | $-1.07 | $-1.03 | $-0.90 | $-0.30 |
| EPS (Diluted) | $-1.36 | $-0.57 | $-0.61 | $-0.36 | $-0.45 | $-0.87 | $-1.07 | $-1.03 | $-0.90 | $-0.30 |
| Shares Outstanding (Diluted) | $4.0M | $9.1M | $12.5M | $13.6M | $16.5M | $19.7M | $24.9M | $25.6M | $33.4M | $46.4M |
Price
| Price | $1.13 |
| Market Cap | $53M |
Related companies: ALXO · ATYR · BYSI · CAMP · CLNN · FBIO · GUTS
More sections of HYFT: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks